Search results for: virus for long term

03 April 2023 Laboratory Testing for SARs-CoV-2 Virus for Long Term Care Facilities Laboratory diagnostic testing for SARS-CoV-2 for long term care facilities 03 April 2023 Open 3/7/2023 10:00 AM MST Type Request for Proposal Close 4/17/2023 5:00 PM MDT Number RFP20232240 Currency US Dollar Sealed Until 4/18/2023 10:30 AM MDT Payment Terms 0% 0, Net 30 03 April 2023 Contacts Thayne Pearson

The Centers for Disease Control and Prevention intends to award a sole source fixed-price purchase order to The Medical College of Wisconsin, Inc., for the procurement of a natural history study of rubella-associated granulomatous lesions in aged individuals.This project will estimate the prevalence of rubella virus (RV)-associated granulomas in normal, aged individuals with cutaneous granulomas and assess the frequency and intensity of virus shedding by these long-term RV carriers. These results will help ascertain the impact of long-term RV carriers on CDC’s programmatic activities aimed on maintenance of rubella elimination in the United States. The Contractor will perform retrospective medical chart reviews t...

Virus IsolationSOURCES SOUGHT: This is a SOURCES SOUGHT NOTICE. The U.S. Geological Survey is conducting a MARKET SURVEY to determine the interest and capability of any sized firm for an upcoming requirement.

SOPHOS ANTI-VIRUS RENEWAL Solicitation ID/Procurement Identifier: CS-92339 Ultimate Completion Date: Mon Mar 11 17:00:00 GMT 2024

These long-term effects could potentially have profound impact on the health and socioeconomic stability of populations living in endemic areas, in addition to the impact of the initial acute illness.Other diseases, such as Chikungunya and Zika, continue to spread across the globe at an alarming rate, and recently entered in the Americas.

agents, their infectivity, and their susceptibility to inactivation/neutralization; 4) prospectively study donors infected with hepatitis C virus (HCV) to determine the natural history and long-term outcome of this infection; 5) study the immunologic, virologic and gene-associated differences between HCV chronic carriers and those who spontaneously recover; 6) study mechanisms of HCV binding to B lymphocytes and downstream effects using deep sequencing

agents, their infectivity, and their susceptibility to inactivation/neutralization; 4) prospectively study donors infected with hepatitis C virus (HCV) to determine the natural history and long-term outcome of this infection; 5) study the immunologic, virologic and gene-associated differences between HCV chronic carriers and those who spontaneously recover; 6) study mechanisms of HCV binding to B lymphocytes and downstream effects using deep sequencing